# Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)

> **NCT04192253** · PHASE2 · RECRUITING · sponsor: **The Netherlands Cancer Institute** · enrollment: 51 (estimated)

## Conditions studied

- Locally Advanced, Squamous Cell Carcinoma of the Vulva

## Interventions

- **DRUG:** Paclitaxel and Carboplatin

## Key facts

- **NCT ID:** NCT04192253
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-14
- **Primary completion:** 2024-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2022-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04192253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04192253, "Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04192253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*